Overlooked brown fat in our bodies linked to wide range of health benefits - Nature
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
Brown fat (shown here in a light-microscopy image) burns calories to generate heat. Credit: Ziad M. El-Zaatari/Science Photo LibraryWhen people think of fat, they typically picture the jiggly tissue around the belly that stores extra calories. That’s white fat. But there’s another type, called brown fat, that does the opposite. Typically found around the neck, armpits and in the chest, brown fat burns calories to generate heat and has been linked to health benefits. Fat cells have a ‘memory’ of obesity — hinting at why it’s hard to keep weight offA study of more than 100,000 people — the largest of its kind — is now expanding that list of benefits. It revealed that people with ‘active’ brown fat are less affected by a number of health issues, including type 2 diabetes, depression and anxiety, than are those without it. Researchers used an artificial-intelligence model to quantify, from scans, the participants’ active brown fat, which is fat that is ‘turned on’ and burning calories. They concluded that the more active brown fat people have, the greater the protection they have from disorders and diseases. The findings were published today in Nature1.
This article is an excerpt. To read the full content, visit the original source. Nature
Related articles
Scientists may have overlooked a hidden Alzheimer's culprit for decades - Science Daily
For decades, researchers have invested billions of dollars in Alzheimer's treatments designed to target amyloid beta, a peptide that forms harmful deposits in the brain. But a biochemist at the University of California, Santa Cruz, believes scientists may have overlooked another potential contributor to the disease: a smaller, closely related peptide that was long considered harmless. In a new commentary published in ChemBioChem, UC Santa Cruz professor Jevgenij Raskatov highlights research suggesting that this lesser-known peptide, called P3, can form microscopic clumps and threadlike structures known as fibrils. Evidence also suggests that P3 may interact with amyloid beta (Aβ), potentially influencing how it accumulates in the brain and how toxic it becomes. These findings raise the possibility that P3 contributes to the nerve cell damage associated with Alzheimer's disease.
Tobacco and infertility: An overlooked public health challenge - World Health Organization (WHO)
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!